WellPrept Patient Education · For your first urology visit

Elevated PSA

Your PSA came back high. This guide walks you through the workup your urologist will run, and what each step is actually trying to answer.

Version 1.0 · May 2026 Medically reviewed · Next review May 2027

Welcome

You are reading this because a PSA blood test came back high. Most men with a moderately high PSA who finish the full workup turn out to have something other than prostate cancer.

Prostate care has changed a lot in the last ten years. The blood and urine markers got better, and an MRI now usually goes before any biopsy. Many practices have also moved to a biopsy needle path that drops the infection rate well below one percent.

How to use this guide. Read it once at your own pace. Skip parts that do not apply. Bring the question pages in Chapter 13 to your visit. If you take finasteride or dutasteride for any reason, including hair loss, jump to Chapter 7 first.

Chapter 01

What an elevated PSA means

PSA is a protein made by the prostate. A small amount leaks into the blood and can be measured. When that number comes back high, it tells your doctor the prostate is doing something that needs a closer look. On its own, it does not say which cause is behind it.

What the prostate makes

Every man with a prostate makes some PSA, and the amount drifts up slowly with age. The PSA blood test does not look for cancer. It looks for prostate activity, which goes up any time the gland is irritated, enlarged, infected, or growing a tumor.

Things that can raise PSA

  • Benign prostatic hyperplasia (BPH). This is the slow enlargement of the prostate that affects most men over 60. It is not cancer.
  • Prostate inflammation or infection. Called prostatitis. PSA can spike a lot when this happens.
  • Recent ejaculation. Within 24 to 48 hours of the blood draw.
  • Hard bicycle riding. Or other pressure on the perineum just before the test.
  • A urinary tract infection.
  • A recent procedure. A catheter, a bladder scope, or a recent biopsy can raise PSA for weeks.
  • Aging. A slow drift up over the years is normal.
  • Prostate cancer.

Why your urologist takes it seriously

Cancer is why an elevated PSA gets a careful look, and it is one of several possible reasons your number is high. At the first visit, your urologist works out which of the items above is driving your number, using the fewest tests it takes to be confident in the answer.

?
If my PSA is high, do I have cancer?

No. Most men with a moderately high PSA who finish the full workup do not have prostate cancer. The follow-up tests are built to sort out who does and who does not.

Chapter 02

Reading your PSA number

A single PSA number rarely tells the full story. Your urologist looks at four things together: the value, your age, how fast it is changing, and how much prostate is making it.

The old cutoff of 4.0

You may have heard that 4.0 ng/mL is the line. That cutoff was set in the early 1990s based on a small group of men, and most urologists now use it as a starting point rather than a hard threshold. The actual read on your number weighs your age, the trend, your prostate size, and the percent free PSA, all at once.

Age-related ranges

PSA tends to rise slowly with age. These ranges are common reference points, not hard cutoffs.

  • Age 40 to 49: under 2.5 ng/mL
  • Age 50 to 59: under 3.5 ng/mL
  • Age 60 to 69: under 4.5 ng/mL
  • Age 70 to 79: under 6.5 ng/mL

A 50-year-old man with a PSA of 3.0 deserves more attention than a 75-year-old man with the same number.

Velocity, density, and free PSA

  • Velocity. How fast the number is rising. A PSA that climbs more than about 0.75 ng/mL in a year, or doubles in a short time, gets a closer look even if the value is in the normal range.
  • Density. Your PSA divided by the size of your prostate. A PSA of 6 in a small gland is more worrisome than a PSA of 6 in a big one. The math uses a volume from an MRI or ultrasound.
  • Percent free PSA. PSA travels in two forms in the blood: a free form and a form bound to proteins. Cancer tends to lower the free part. A free PSA below 10 percent raises concern. Above 25 percent is more reassuring.

One number is rarely enough

Your urologist will almost always want to repeat the PSA in a few weeks. This is true any time something might have raised the first one. Recent sex, hard exercise, an infection you did not notice, or a recent procedure can all raise the value.

i
My PSA went from 5 to 5.5. Is it getting worse?

Maybe, maybe not. PSA bounces around day to day, lab to lab, and with normal prostate activity. A trend across three or more values over a year or two means more than any single comparison.

Chapter 03

Why screening advice has shifted

You may have heard mixed advice about PSA testing from your doctor, a friend, or the news. The official advice has changed more than once over the years, for reasons that are easier to follow once you see the timeline.

A short timeline

  • 1990s to 2008. PSA testing spread fast after FDA approval. Detection went up, and so did surgery and radiation for cancers that may never have caused harm.
  • 2012. The U.S. Preventive Services Task Force recommended against routine PSA screening for all men. The concern was overdiagnosis and overtreatment.
  • 2018. The same Task Force changed course. For men aged 55 to 69, the choice to screen should be a shared talk between you and your doctor about benefits and harms. For men 70 and over, routine screening is still not recommended.

What changed

Two large screening trials (ERSPC in Europe and PLCO in the U.S.) followed men for more than a decade. The European trial showed that regular PSA screening lowers death from prostate cancer by about 20 to 25 percent. Overtreatment drove the original pushback. Since the 1990s, three practice changes have cut down on that problem. Doctors now use active surveillance for low-risk cancer, MRI before biopsy instead of needling everyone, and better blood and urine markers to sort the borderline cases.

Where major societies stand now

  • USPSTF (U.S. Preventive Services Task Force). For ages 55 to 69, the choice to screen should be a shared talk with your doctor. Routine screening is not advised at age 70 or older.
  • NCCN (National Comprehensive Cancer Network). Discuss a baseline PSA at age 45. Earlier (age 40) for higher-risk groups.
  • ACS (American Cancer Society). Shared talk starting at 50 for average risk. Age 45 for higher risk. Age 40 for the highest risk.
!
Why your doctor said something different

Different medical societies give different advice, and primary care guidance does not always match urology guidance. If a friend was told one thing and you were told another, both can be reasonable. Your plan should be built on your own numbers.

Chapter 04

The workup ladder

Most men with an elevated PSA move through some version of the same set of steps. Not every step is needed for every man. Each rung answers a question that might let you skip the next one.

1

Repeat the PSA, plus a urine check

A second PSA, drawn weeks later after no sex for 48 hours and no infection. A urine test screens for a quiet bladder infection. Many "elevated" PSAs come down on the second draw. If the repeat is normal, your urologist may simply recheck in 6 to 12 months.

2

History, exam, and risk picture

A short talk about family cancer history, your meds, and any urinary symptoms. Make sure to mention finasteride or dutasteride. A brief rectal exam checks for hard spots. An abnormal exam can change the plan, even if your PSA looks fine.

3

Sharpen the PSA picture

Three add-ons can clarify a borderline number. Free PSA. PSA density, using a prostate size. PSA velocity, using a few values over time.

4

A blood or urine biomarker, if needed

Tests like 4Kscore, PHI, SelectMDx, ExoDx, and MyProstateScore use newer markers to estimate the chance of finding meaningful cancer. A reassuring result can spare you a biopsy.

5

A prostate MRI (multiparametric)

Standard at most academic centers in 2026. The MRI is read on a 1 to 5 scale called Prostate Imaging Reporting and Data System (PI-RADS). A reassuring score can mean no biopsy today. A high score points the biopsy needle right at the lesion.

6

A prostate biopsy, if it is needed

A small needle takes tiny tissue samples for the pathologist. Modern practice favors aiming the needle at any MRI lesion, on top of a standard sampling pattern.

Your visit may use only the first one or two rungs, or it may use all six. Each step is meant to spare you the tests you do not need.

Chapter 05

MRI before biopsy

This is the biggest change in prostate cancer testing in the last ten years. The MRI now goes before the biopsy at most major centers, and a reassuring scan can sometimes mean no biopsy at all.

What the MRI does

A prostate MRI uses a few different imaging methods together. A specialist radiologist reads the scan and scores any suspicious area on the PI-RADS scale, from 1 (very low) to 5 (very high). The score is the radiologist's read on how likely it is that meaningful cancer is present.

1
Very low
Meaningful cancer is very unlikely.
2
Low
Meaningful cancer is unlikely.
3
Borderline
Gray zone. Other tests help decide.
4
High
Meaningful cancer is likely.
5
Very high
Meaningful cancer is very likely.

What each score may mean

  • PI-RADS 1 or 2. Many men with reassuring blood or urine markers can defer a biopsy and stay on a PSA watch. This does not promise that no cancer exists. It means the chance of missing a meaningful cancer is low enough to wait.
  • PI-RADS 3. Gray zone. Your urologist weighs PSA density, free PSA, and biomarker results to decide. Some men go to biopsy. Others go to closer follow-up.
  • PI-RADS 4 or 5. A biopsy is recommended, with the needle aimed at the MRI lesion.

Why this is better than the old way

  • Higher catch rate for the cancers that matter (the ones that can spread).
  • Lower catch rate for the slow cancers that drive worry without changing outcome.
  • Fewer biopsies overall, because some men can safely wait.
  • Better aim when a biopsy is needed.
!
Caveats

Reading prostate MRI takes special training. Reads are best at high-volume centers. A small share of meaningful cancers are missed even on a good read, which is why your urologist combines it with PSA density and a marker. Insurance coverage for pre-biopsy MRI has improved but is not universal. Ask.

Chapter 06

The prostate biopsy

A biopsy is the only way to say for sure whether prostate cancer is present. Imaging can point to a suspicious area, but it cannot settle the question.

WatchYour prostate biopsy, explainedA short video, on YouTube (youtu.be/2AtI1uX0xDk)

What is taken

A thin needle pulls a few small samples of prostate tissue. A standard pattern takes about 12 cores, and two to four extra cores can be aimed at any MRI lesion. Some urologists take more cores than others. The number varies from one doctor and one center to the next. A pathologist examines every core under the microscope.

Two needle paths

 Transrectal ultrasound (TRUS)Transperineal
Needle pathThrough the rectal wallThrough the skin between scrotum and anus
Where it is doneOffice, local numbingOffice, local numbing, or brief sedation
Infection riskAbout 1 to 3 percent, even with antibioticsOften less than 0.5 percent
Front of the prostateHarder to reachEasier to reach

The transrectal path is still the most common approach in many urology offices. Some offices use a rectal swab culture and targeted antibiotics, which has lowered the infection rate further. The transperineal path is offered more often now and avoids the rectum, which lowers the chance of infection. Either path is reasonable. Ask your urologist which one fits your case.

Targeted, systematic, or both

If your MRI showed a lesion, today's approach combines both. The 12-core pattern catches cancer the MRI may have missed. The extra targeted cores aim at the MRI lesion.

What to expect after

  • Home the same day. Normal activity within 24 to 48 hours.
  • Blood in your urine for several days. Common.
  • Blood in your semen for 4 to 6 weeks. Also common, and not dangerous.
  • Soreness with urination for a few days.
!
Call urgently after a biopsy if

You run a fever above 100.4°F. Chills come on, or you feel broadly unwell. You cannot urinate. Your bleeding is heavy and does not stop. Your pain gets worse instead of better. Call your urologist the same day for any of these.

Chapter 07

Finasteride and the halving rule

If you take finasteride or dutasteride for any reason, your PSA number does not mean what the lab report says it means. The drug cuts the value roughly in half, so it has to be doubled before anyone can read it properly.

How the rule works

If you have been on finasteride or dutasteride for at least six months, your PSA is roughly half of what it would be without the drug. Your urologist doubles the measured number to get a fair read.

On finasteride or dutasteride for six months or more? Double the PSA your lab reports. That is the number your urologist uses.

This includes hair loss doses

Finasteride is sold under two brand names with two different doses. Both lower PSA.

  • Proscar (5 mg). Used for benign prostate enlargement.
  • Propecia (1 mg). Used for hair loss.
  • Avodart (dutasteride). Used for benign prostate enlargement.

The 1 mg dose for hair loss is enough to lower your PSA, and many men on Propecia do not realize this. A man on Propecia for years can have a PSA of 2.5 that should be read as 5.0. Tell your urologist the drug and the dose so the number gets doubled.

Three things to know

  • The drug does not protect you from prostate cancer. It only lowers the PSA number. The cancer risk stays.
  • If you start a 5-alpha reductase inhibitor (5-ARI), get a baseline PSA first. Your urologist uses that number as the baseline for tracking changes later.
  • Any rising PSA on a 5-ARI deserves a urology look. A doubled number that keeps climbing is a signal, even if the lab value still looks low.
+
Tell every doctor you see

Bring your medication list to every visit. Make sure finasteride or dutasteride is on it, with the dose. If your primary care doctor checks your PSA, remind them to double it.

Chapter 08

Race, family, and inherited risk

Both family history and ancestry shape your risk picture. Your urologist works through both with you.

Black men face a higher burden

  • About 1.7 times the rate of prostate cancer of white men.
  • About twice the death rate.
  • Younger average age at diagnosis.
  • More aggressive disease in some studies at the time it is found.

The reasons are mixed. They include tumor biology, access to care, screening patterns, and years of being left out of research. In clinic it changes one concrete thing. If you are Black, NCCN and the American Cancer Society both advise the first PSA talk between age 40 and 45 instead of the usual 50.

Family history matters too

  • A father or brother with prostate cancer roughly doubles your risk.
  • Two first-degree relatives roughly triples it.
  • Cancer in a relative under 65 raises risk further.

It can also matter if close relatives had cancer of the breast, ovary, or pancreas. So can a family history of fast-growing prostate cancer. The BRCA2 gene is linked to prostate cancer that is more aggressive and starts younger.

Genetic counseling

Most readers of this guide do not need genetic testing today. Reasons your urologist may suggest a counselor visit:

  • A relative with a known BRCA1, BRCA2, or Lynch syndrome gene change.
  • Two or more relatives who had breast, ovary, pancreas, or prostate cancer.
  • Ashkenazi Jewish ancestry.
  • A relative with prostate cancer at a young age, or with spread.
Chapter 09

What you can do before the visit

Some of the steps below change the PSA result itself. The rest give your urologist history that changes what gets ordered next.

Help your PSA tell the truth

  • No ejaculation for 48 hours before any PSA blood draw. This includes sex and masturbation.
  • No hard bicycle riding for 48 hours before any PSA blood draw. Pressure on the perineum can raise the number.
  • If you may have an infection, say so. A urinary tract infection can spike PSA. Better to delay the draw than to read a falsely high number.
  • Mention any recent procedures. A catheter, a bladder scope, or a recent biopsy can raise PSA for weeks.

Bring your history with you

  • Your prior PSA values. Even old ones. A trend across years tells your urologist more than any single number. Ask your primary care office to print or send your lab history before the visit.
  • Your full medication list. Include over-the-counter pills, herbs, and any testosterone. Be sure finasteride, Propecia, dutasteride, and any anabolic agents are listed.
  • Your family history. Cancer in parents, siblings, and children. Type of cancer and rough age at diagnosis. Pancreatic, ovarian, breast, and prostate cancer are the patterns urology cares most about.

Bring a question list and a person

Write down three or four questions before you go, and bring someone with you. A spouse, an adult child, or a friend can catch things you will miss when you are nervous. Helpful starters:

  • "Why are you ordering this test, and not that one?"
  • "What would change your mind about whether to biopsy?"
  • "Based on what we know now, what is my chance of meaningful cancer?"

Two questions to ask up front

  • Is a prostate MRI right for me before any biopsy?
  • If I need a biopsy, do you offer the transperineal path? What is your infection rate?
Chapter 10

When to call urgently

A few problems, almost all of them after a biopsy, need a same-day call. Everything else in this guide plays out over weeks and months.

Same-day call after a biopsy

  • You run a fever above 100.4°F (38°C). Call even if nothing else feels wrong.
  • Chills or shaking set in, or you feel broadly unwell. Sepsis can start this way.
  • You cannot urinate. A swollen prostate can block flow for a short time after biopsy.
  • You are bleeding heavily, or the bleeding keeps going in urine, stool, or semen, beyond what your urologist told you to expect.
  • Your perineal or rectal pain gets worse instead of better.

Reasons to come in for routine evaluation

  • Your PSA is above the age-related range.
  • Your PSA has risen substantially from your prior values, even if it is still in range.
  • Your digital rectal exam was abnormal, no matter what your PSA is.
  • You have close family with prostate, breast, ovary, or pancreas cancer, and no PSA talk yet.
  • You are a Black man aged 40 to 45 and have not had a baseline PSA talk.
  • You take finasteride or dutasteride and your PSA has risen from its post-treatment baseline.

When the workup finds no cancer

Most men who finish this workup end here. The usual plan is a recheck PSA every 6 to 12 months, sometimes with a follow-up MRI a year later, and no biopsy at all.

A PI-RADS 1 or 2 MRI plus a reassuring marker test is the combination that most often supports watching your PSA instead of doing a biopsy. Your urologist will set the recheck interval and put it on the calendar before you leave the office. Keeping that schedule matters more than any single value, since one draw is only one point in a trend.

i
Living with watch-and-wait

Some men live with a slightly elevated PSA for years, with regular checks and nothing more. The wait between blood draws can wear on you. Tell your urologist if it does. There may be ways to space out your visits, or to add an MRI to settle a worry, that fit your case.

Chapter 11

If your biopsy is positive

A small share of men reading this guide will end with a biopsy that finds cancer. The diagnosis often arrives in a five-minute phone call, and the next steps take several weeks.

What you will see on the report

Prostate cancer is reported core by core. Each positive core is given a Gleason score, which is converted into a Grade Group from 1 to 5. Grade Group 1 is the slowest. Grade Group 5 is the most aggressive. Many newly found prostate cancers are Grade Group 1 or 2.

The pathology report also notes the percent of each core that is cancer, and any extra features the pathologist saw. The full reading takes time. A normal flow is a results call within a week, then a longer visit to talk through what was found.

Grade Group 1 and active surveillance

Grade Group 1 prostate cancer is now widely managed with active surveillance. That means a planned schedule of PSA tests every 6 months and a repeat MRI in about 12 to 18 months. Sometimes there is a confirmatory biopsy at the one-year mark. Treatment is held back unless the cancer shows it is changing. Most men ask within the first ten minutes whether the prostate can just come out. For Grade Group 1 disease, the long-term cancer outcomes on surveillance match those on surgery, and you keep the urinary and sexual function you started with.

Active surveillance and watchful waiting

Active surveillance is close monitoring of a cancer your team still plans to cure if it changes. It means PSA tests, scans, and repeat biopsies on a set schedule. The point is to catch a change early, while treatment still works.

Watchful waiting is lighter. It is often PSA alone, with no repeat biopsies. Your team offers it when treatment would not be the plan even if the cancer grew, usually because of age or other health problems. If symptoms come up, they get treated. The goal is to keep you comfortable.

Where to read next

  • WellPrept Cancer Basics primer. The shared cancer words. What grade and stage mean. How to read a pathology report. Active surveillance. Reading survival numbers honestly. Genetic testing.
  • WellPrept Localized Prostate Cancer guide. Picks up where this guide ends. Walks through the choice between active surveillance, surgery, radiation, and other options for cancer that has not spread. Side effects, recovery, and the questions to ask are covered there.

What to expect in the next two weeks

  • A staging plan. Sometimes more imaging, sometimes none, depending on your numbers.
  • A second-opinion option, if you want one. Major cancer centers welcome them.
  • A talk about whether your cancer calls for genetic testing.
  • Time to think. With most prostate cancer, you have weeks to decide.
+
A note on time

The week after a positive biopsy is when men most often rush to pick a treatment. For low- and intermediate-risk prostate cancer, the data say that waiting 6 to 8 weeks to start does not change your outcome. That is time to read and to bring a partner to the next visit. It also leaves room for a second opinion if you want one.

Chapter 12

Questions every patient asks

?

If my PSA is high, do I have prostate cancer?

Probably not. Most men with a moderately high PSA who finish the workup do not have cancer. The next tests sort out who does and who does not.

?

Should I worry if my PSA went from 5 to 5.5?

Maybe, maybe not. PSA bounces around day to day and lab to lab. Trends across three or more values over a year or two mean more than any single jump.

?

I take finasteride for hair loss. Does it mess up my PSA?

Yes. Finasteride lowers PSA at any dose, including the 1 mg used for hair loss. Your urologist needs to know. The fix is to double the lab value to estimate your true PSA.

?

Can I skip the biopsy if my MRI is reassuring?

Sometimes, yes. With a PI-RADS 1 or 2 MRI and reassuring marker tests, many urologists will hold off on the biopsy and watch the PSA. This is a careful judgment call, and it does not rule cancer out for certain.

?

Is the biopsy going to hurt?

Most men describe pressure and pinching, not sharp pain. Local numbing is used. The whole procedure takes 20 to 30 minutes. Soreness, blood in urine, and blood in semen are normal for a few weeks.

?

Should I ask for the transperineal biopsy?

Yes, ask. It has a much lower infection rate than the rectal path. Not every practice offers it, and the rectal path is still reasonable when antibiotics are used carefully.

?

My father had prostate cancer. Should I be tested earlier?

Yes. A father or brother with prostate cancer roughly doubles your risk. NCCN family-risk guidance suggests a first PSA talk between age 40 and 45.

?

I am Black. Does that change my screening?

It can. Black men face about 1.7 times the rate of prostate cancer and about twice the death rate. NCCN and the American Cancer Society suggest starting the screening talk between age 40 and 45.

?

What if my biopsy is negative?

Most often, the next step is regular PSA checks and sometimes a repeat MRI in a year or so. A negative biopsy is reassuring for now. It does not settle the question forever, so the PSA checks continue.

?

Will all of this hurt my sex life or my urine flow?

A blood draw, an MRI, and a single biopsy do not change your long-term sex life or urine flow. Treatment for prostate cancer can. That decision lives in the localized prostate cancer guide.

Chapter 13

Questions to ask your team

Bring this page to your visit. The right talk is hard to have on the spot.

About the number itself

  • What is my PSA, and how does it compare to my prior values?
  • Could anything I did before the test (sex, biking, infection) have changed it?
  • Should we repeat the PSA before doing anything else?
  • Am I on any drug that lowers PSA, like finasteride or dutasteride?

About the next test

  • What is the next test you would order, and why?
  • Would a free PSA, PSA density, or PSA velocity change the picture?
  • Are there blood or urine markers (4Kscore, PHI, SelectMDx, ExoDx, MyProstateScore) that you use here?
  • Is a prostate MRI right for me before any biopsy?

About the biopsy, if it comes up

  • What would change your mind about whether to biopsy?
  • Do you offer transperineal biopsy? What is your office's infection rate?
  • If we biopsy, will you target any MRI lesion, plus do the standard pattern?
  • What antibiotics will I get, and what should I watch for after?

About my risk picture

  • Does my family history change what you would do next?
  • Should I see a genetic counselor?
  • How does my age factor into this plan?

About the bigger plan

  • What is my chance of having a meaningful cancer based on what we know now?
  • If today's tests are reassuring, when should I be checked again?
  • Who do I call between visits if a question comes up?
Chapter 14

Words to know

Most patients meet these terms for the first time when a PSA comes back unusual. The short definitions below match the way your urologist will use them.

5-ARI
5-alpha reductase inhibitor. A class of drug that includes finasteride and dutasteride. Lowers PSA by about half.
4Kscore
A blood test that mixes four markers with clinical factors to estimate the chance of meaningful prostate cancer.
Active surveillance
A planned program of close monitoring for low-risk cancer, with a plan to treat if it changes.
BPH
Benign prostatic hyperplasia. The non-cancerous enlargement of the prostate that affects most older men.
BRCA1, BRCA2
Inherited cancer-risk genes. BRCA2 is linked to more aggressive prostate cancer.
Digital rectal exam (DRE)
A short physical exam of the prostate through the rectum.
Dutasteride (Avodart)
A 5-ARI used for benign prostate enlargement. Lowers PSA.
ExoDx Prostate
A urine test that uses gene markers to estimate cancer risk.
Finasteride (Proscar, Propecia)
A 5-ARI used for benign prostate enlargement (5 mg) and hair loss (1 mg). Lowers PSA at both doses.
Free PSA
The unbound part of PSA. A low percent free PSA raises concern for cancer.
Gleason score / Grade Group
A measure of how aggressive prostate cancer cells look. Used to grade cancer if biopsy is positive.
Lynch syndrome
An inherited gene change linked to several cancers, including prostate.
mpMRI
Multiparametric MRI. A detailed prostate scan that uses several imaging methods together.
MRI-targeted biopsy
A biopsy that aims extra cores at lesions seen on MRI.
MyProstateScore
A urine test that combines two genetic markers to estimate cancer risk.
PHI
Prostate Health Index. A blood test that combines three forms of PSA.
PI-RADS
The 1-to-5 scale a radiologist uses to score prostate MRI findings.
Prostatitis
Inflammation or infection of the prostate. Can spike PSA.
PSA
Prostate-specific antigen. A protein made by the prostate and measured in the blood.
PSA density
The PSA value divided by prostate size. Higher density raises concern.
PSA velocity
How fast PSA is rising over time.
SelectMDx
A urine test that uses gene markers, taken after a digital rectal exam.
Shared decision-making
A structured talk between patient and clinician about whether to test or treat.
Systematic biopsy
A standard 12-core sampling pattern of the prostate.
Transperineal biopsy
A biopsy that uses the skin between scrotum and anus. Lower infection risk.
Transrectal (TRUS) biopsy
A biopsy that uses the rectal wall as the needle path.
USPSTF
U.S. Preventive Services Task Force. Sets national screening recommendations.
Watchful waiting
Lighter monitoring of a known cancer, often PSA alone with no repeat biopsies. Used when treatment would not be the plan even if the cancer grew. Not the same as active surveillance.
Sources

Sources and further reading

This guide draws on the major society guidelines and the trials behind the modern workup. Most of the sources below are written in plain language for patients.

  1. USPSTF: Prostate Cancer Screening (Grade C, ages 55 to 69). uspreventiveservicestaskforce.org
  2. NCCN Guidelines for Patients: Prostate Cancer Early Detection. nccn.org/patients
  3. American Cancer Society: Prostate Cancer Screening. cancer.org
  4. NCI Fact Sheet: PSA Test. cancer.gov
  5. PRECISION trial: MRI-targeted vs standard biopsy (NEJM, 2018). nejm.org
  6. PROMIS trial: mpMRI accuracy in biopsy-naive men (Lancet, 2017). thelancet.com
  7. PI-RADS v2.1 (American College of Radiology). acr.org
  8. NCCN: Genetic / Familial High-Risk Assessment Prostate. nccn.org
  9. WellPrept Cancer Basics primer. Shared cancer vocabulary, grade and stage, pathology reports, active surveillance, genetic testing.
  10. WellPrept Localized Prostate Cancer guide. Picks up if your biopsy is positive. Active surveillance, surgery, radiation, side effects, recovery.

About this guide. Written by the WellPrept Clinical Team and reviewed by board-certified urologists. Read it alongside your urologist's instructions, and bring the questions in Chapter 13 to your visit.

Playing audio...